Omada Health

OMDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$21.42

+$0.81 (+3.93%)

Sep 22, 2026, 2:02 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.23B

Enterprise Value $1B

Beta 1.85

Average Volume 1.27M

Shares Outstanding (Diluted) 63.95M

Shares Change YoY 11.56%

Institutional Ownership 81.74%

Exchange NASDAQ

ISIN US68170A1088

Price Performance

Price Change 1M -13.8%

Price Change 3M 12.6%

Price Change 6M 59.0%

Price Change YTD 38.3%

Price Change 1Y -11.6%

Price Change 3Y -10.4%

Price Change 5Y -10.4%

1M CAGR (ann.) -12.9%

1Y CAGR (ann.) -9.4%

5Y CAGR (ann.) N/A

All-Time CAGR -8.1%

Valuation

PE Ratio 327.14

Forward PE 46.99

PEG Ratio 0.49

Forward PEG 8.47

PS Ratio 3.96

Forward PS 3.00

PB Ratio 4.85

P/FCF Ratio 192.47

P/Adj. FCF Ratio -81.88

P/OCF Ratio 51.52

EV/Sales 3.24

EV/EBIT 230.69

EV/EBITDA 85.38

EV/FCF 157.64

Earnings Yield 0.3%

FCF Yield 0.5%

Adj. FCF Yield -1.2%

Financial Health

Net Cash $221.71M

Total Debt $0

Cash & Short-Term Investments $221.71M

Total Assets $328.22M

Current Ratio 3.91

Quick Ratio 3.85

Debt / Equity Ratio 0.00

Debt / EBITDA 0.00

Debt / FCF 0.00

OCF / Debt N/A

Interest Coverage -1.17

Altman Z-Score 9.59

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 68.2%

Operating Profit Margin -0.1%

EBITDA Margin 3.8%

Net Profit Margin 1.4%

FCF Margin 2.1%

Adj. FCF Margin -4.8%

SBC / Revenue 5.5%

SBC Impact (per share) -335.1%

Returns

Return on Assets 1.3%

Return on Equity 1.8%

Return on Invested Capital -0.2%

Return on Capital Employed -0.2%

Return on Tangible Assets 1.4%

Historical Growth (CAGR)

Revenue CAGR 3Y 42.9%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 65.1%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y 141.5%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 13

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y 17.7%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) $0.09

EPS Growth Est (next Q) -250.0%

Revenue Est (next Q) $85.43M

Revenue Growth Est (next Q) 25.6%

Fair Value Estimates

Graham Number $2.45

Graham Upside -88.1%

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $25.88

Price Target Upside 25.6%

Cash Flow

Operating Cash Flow $11.85M

Free Cash Flow $6.37M

Adj. Free Cash Flow $-14.96M

FCF Per Share $0.38

OCF Per Share $0.40

OCF/S Ratio 7.6%

Income Statement

Revenue $309.76M

Gross Profit $211.21M

Operating Income $-464K

EBITDA $11.75M

Net Income $4.31M

EPS (Diluted) $0.06

Revenue / Employee $327.44K

Profit / Employee $4.55K

Employees 946